These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26169405)

  • 21. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
    Simonetti O; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mazzocato S; Kamysz W; Kamysz E; Provinciali M; Giacometti A; Guerrieri M; Offidani A
    Peptides; 2014 May; 55():17-22. PubMed ID: 24531033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
    Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
    Dosler S; Karaaslan E; Alev Gerceker A
    J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
    Choi MJ; Ko KS
    J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
    Plachouras D; Giamarellos-Bourboulis EJ; Kentepozidis N; Baziaka F; Karagianni V; Giamarellou H
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):419-22. PubMed ID: 17188449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria.
    Deris ZZ; Swarbrick JD; Roberts KD; Azad MA; Akter J; Horne AS; Nation RL; Rogers KL; Thompson PE; Velkov T; Li J
    Bioconjug Chem; 2014 Apr; 25(4):750-60. PubMed ID: 24635310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
    Kavanagh A; Ramu S; Gong Y; Cooper MA; Blaskovich MAT
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
    Choi MJ; Park YK; Peck KR; Ko KS
    Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
    [No Abstract]   [Full Text] [Related]  

  • 30. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
    Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii.
    Knezevic P; Aleksic V; Simin N; Svircev E; Petrovic A; Mimica-Dukic N
    J Ethnopharmacol; 2016 Feb; 178():125-36. PubMed ID: 26671210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
    Yokota SI; Hakamada H; Yamamoto S; Sato T; Shiraishi T; Shinagawa M; Takahashi S
    Int J Antimicrob Agents; 2018 Jun; 51(6):888-896. PubMed ID: 29432867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
    Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
    Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
    [No Abstract]   [Full Text] [Related]  

  • 34. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
    Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin.
    Sader HS; Rhomberg PR; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):412-4. PubMed ID: 23102558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
    Hostacká A; Ciznár I
    Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):101-5. PubMed ID: 18767377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.